Award recordCONTRACT

TRI-PHARMA, INC.

PIID 36C77019P0863· VHA· NATIONAL CMOP OFFICE (36C770)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $547,400 net obligations· UEI P2EDVGEMBDB3· GA

Description

RX BUSPIRONE MOD 1 - CHANGE NDCS QTYS - ADD LINE ITEMS - NO CHANGE COST MOD 2 - CHANGE NDCS QTYS - ADD LINE ITEMS - NO CHANGE COST

Base award description: RX BUSPIRONE

First action · last action
2019-05-21 · 2019-06-11
Transactions
3
First transaction's obligation
$547,400
Base + all options value (sum of deltas)
$547,400
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$547,400$0Base award · 2019-05-21 · this action $547,400 · running total $547,400Modification P00001 · 2019-06-05 · this action $0 · running total $547,400Modification P00002 · 2019-06-11 · this action $0 · running total $547,400
  • Base2019-05-21+$547,400= $547,400
  • Mod P000012019-06-05+$0= $547,400
  • Mod P000022019-06-11+$0= $547,400
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-05-21+$547,400$547,400RX BUSPIRONE
Mod P00001· OTHER ADMINISTRATIVE ACTION2019-06-05+$0$547,400RX BUSPIRONE MOD 1 - CHANGE NDCS QTYS - ADD LINE ITEMS - NO CHANGE COST
Mod P00002· OTHER ADMINISTRATIVE ACTION2019-06-11+$0$547,400RX BUSPIRONE MOD 1 - CHANGE NDCS QTYS - ADD LINE ITEMS - NO CHANGE COST MOD 2 - CHANGE NDCS QTYS - ADD LINE IT…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI P2EDVGEMBDB3)

AwardOffice · PSC / listingNet obligationsFY
36C24524P0439245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$74,190FY2024
36C26024P0196260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$61,142FY2024
36C77020P0976NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$706,085FY2020
36C24120P0825241-NETWORK CONTRACT OFFICE 01 (36C241) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$135,790FY2020
36C24520P0679245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$63,600FY2020
36C24420P0540244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$325,350FY2020

Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C77026P0118HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$30,935FY2026
36C77026P0129DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$76,656FY2026
36C77026P0127DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$58,395FY2026
36C77026P0086SAGENT PHARMACEUTICALS, INCNATIONAL CMOP OFFICE (36C770)$275,580FY2026
36C77026P0095HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$83,520FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77019P0863_3600_-NONE-_-NONE- · retrieved 2026-09-26.